News › Industry News, Patient Care, Practice Management

Merz Aesthetics Presents Xeomin (incobotulinumtoxinA) Patient Outcomes in Live Webinar Feb 19

January 22, 2026

Merz Aesthetics Exchange (MAX) invites AmSpa Members and the medical aesthetic community to a virtual, live webinar on February 19 featuring MAX Expert Panel insights on Xeomin (incobotulinumtoxinA) Patient Outcomes: Why They Matter to Your Practice.

MAX Education Partners Kirstie Jackson (AmSpa), Marlee Bruno, MMS, PA-C, CLMC (Mind Body & Soul Medical), Bita Ardakani-Akrawi, PA-C, MPH, MEP-C (Naples Skin Clinic), and Christin Trujillo (Maven Financial Partners) discuss different Xeomin journeys within practices, and how patient outcomes drive practice success.

Xeomin (incobotulinumtoxinA) Patient Outcomes: Why They Matter to Your Practice

Virtual Live Webinar
February 19, 2026
8 – 9:30 p.m. EST 
 

REGISTER NOW

Full prescribing information, including boxed warning and medication guide are available at xeominaesthetic.com.

Topics in Article

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • SkinStylus Receives New FDA Clearance for the Improvement of Periorbital Wrinkles for All Skin Types
    • GlossGenius Becomes Platinum Vendor Affiliate with the American Med Spa Association
    • Medicare GLP-1 Bridge Program Launches July 1, Expanding Access for Some Patients
    • Universal Healthcare Consulting Becomes Platinum Vendor Affiliate with the American Med Spa Association
    • DAW Systems Earns First Artificial Intelligence Accreditation from DirectTrust
Advertisement